Redeployment
Medical Director, Early Phase Clinical Development (San Diego)
Redeployment, San Diego, California, United States, 92189
LOCATION : San Diego, CA; willingness to travel up to 25% (global and domestic)
EMPLOYMENT TYPE : Full-Time
COMPENSATION:
$340-384K (DOE), healthcare, 401k, PTO; additional benefits provided on a per-person basis Company Description A clinical-stage biotechnology company focused on advancing novel therapeutics in oncology and hematology. The organization fosters a collaborative, fast-paced environment where experienced professionals drive high-quality clinical development. About the Job The Medical Director will lead early-phase clinical development programs, providing medical and strategic oversight for clinical trial design, execution, and regulatory engagement. This senior/executive level role requires deep expertise in oncology or hematology, experience with Phase 1 trials, and the ability to collaborate across diverse internal and external stakeholders. What Youll Do Provide clinical and strategic input to senior leadership on drug development programs. Collaborate with preclinical and discovery teams to guide the advancement of new molecules. Design and implement early-phase clinical development plans. Lead or contribute to the development and review of study documents to ensure accuracy and regulatory alignment. Represent the company in regulatory interactions as a clinical subject matter expert. Oversee, initiate, and conduct clinical studies for assigned compounds in alignment with the clinical development plan. Analyze and interpret clinical data, providing medical insight to support decision-making and guide study conduct. Build and maintain relationships with key opinion leaders, clinical investigators, and study sites. Maintain proactive partnerships with external stakeholders globally, focusing on local needs and priorities. Support site engagement, vendor partnerships, and start-up activities. Ensure compliance with ICH, GCP, and regulatory requirements across all studies. Stay current on emerging treatments and therapeutic area trends. Collaborate extensively with peers and across the organization to ensure studies are efficient and operationalized with a patient-first approach. Qualifications Required: MD or MD/PhD with expertise in oncology and/or hematology. Minimum 3 years of early-phase clinical development experience in pharma or biotech. Phase 1 trial experience in solid tumors or hematologic malignancies (small molecule preferred). Strong knowledge of clinical trial design, drug development, and regulatory expectations. Ability to operate independently to support the design and execution of enabling projects and/or clinical trials globally. Ability to solve complex problems and communicate clearly to varied audiences. Comfortable making sound decisions in ambiguous or fast-changing environments. Reports to : SVP, Clinical Development Works closely with : Preclinical, Drug Discovery, Clinical Operations, Regulatory Affairs, external investigators, and vendors About The Company Our client is an innovative biotechnology company advancing a pipeline of novel therapeutics across multiple indications. With an experienced leadership team and a commitment to high-quality clinical development, the company fosters a collaborative environment where cross-functional teams drive meaningful progress for patients.
$340-384K (DOE), healthcare, 401k, PTO; additional benefits provided on a per-person basis Company Description A clinical-stage biotechnology company focused on advancing novel therapeutics in oncology and hematology. The organization fosters a collaborative, fast-paced environment where experienced professionals drive high-quality clinical development. About the Job The Medical Director will lead early-phase clinical development programs, providing medical and strategic oversight for clinical trial design, execution, and regulatory engagement. This senior/executive level role requires deep expertise in oncology or hematology, experience with Phase 1 trials, and the ability to collaborate across diverse internal and external stakeholders. What Youll Do Provide clinical and strategic input to senior leadership on drug development programs. Collaborate with preclinical and discovery teams to guide the advancement of new molecules. Design and implement early-phase clinical development plans. Lead or contribute to the development and review of study documents to ensure accuracy and regulatory alignment. Represent the company in regulatory interactions as a clinical subject matter expert. Oversee, initiate, and conduct clinical studies for assigned compounds in alignment with the clinical development plan. Analyze and interpret clinical data, providing medical insight to support decision-making and guide study conduct. Build and maintain relationships with key opinion leaders, clinical investigators, and study sites. Maintain proactive partnerships with external stakeholders globally, focusing on local needs and priorities. Support site engagement, vendor partnerships, and start-up activities. Ensure compliance with ICH, GCP, and regulatory requirements across all studies. Stay current on emerging treatments and therapeutic area trends. Collaborate extensively with peers and across the organization to ensure studies are efficient and operationalized with a patient-first approach. Qualifications Required: MD or MD/PhD with expertise in oncology and/or hematology. Minimum 3 years of early-phase clinical development experience in pharma or biotech. Phase 1 trial experience in solid tumors or hematologic malignancies (small molecule preferred). Strong knowledge of clinical trial design, drug development, and regulatory expectations. Ability to operate independently to support the design and execution of enabling projects and/or clinical trials globally. Ability to solve complex problems and communicate clearly to varied audiences. Comfortable making sound decisions in ambiguous or fast-changing environments. Reports to : SVP, Clinical Development Works closely with : Preclinical, Drug Discovery, Clinical Operations, Regulatory Affairs, external investigators, and vendors About The Company Our client is an innovative biotechnology company advancing a pipeline of novel therapeutics across multiple indications. With an experienced leadership team and a commitment to high-quality clinical development, the company fosters a collaborative environment where cross-functional teams drive meaningful progress for patients.